Active, not recruitingPhase 4NCT06918080

Hepatoprotective Measures for Children at High Risk of NAFLD

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ain Shams University
Principal Investigator
Manal H El-Sayed, Professor of pediatrics
Ain Shams University-Faculty of Medicine-Pediatric Department
Intervention
Ursodeoxycholic Acid 250 Mg Oral Capsule(drug)
Enrollment
200 enrolled
Eligibility
5-18 years · All sexes
Timeline
20232025

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06918080 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials